Postdoctoral Research Fellow
Lauric Ferrat is an applied mathematician. With a background in the development of mathematical models of biological processes and applications in medicine, his research focuses on machine learning and statistical tools.
In July 2018, he joined the University of Exeter Medical School as a postdoctoral research fellow, working on the prediction of type one diabetes in children using genetic, environmental and clinical risk factors. His main collaborators at RILD are Dr Richard Oram and Prof. Mike Weedon, and he works in close collaboration with Profs Jonathan Fielsend (University of Exeter), Kendra Vehik (University South Florida) and William Hagopian (Pacific Northwest Diabetes Research Institute). Lauric is also undertaking research into the prediction of the onset of celiac disease, and supports his collaborators in their other projects.
He completed his engineering diploma at the National School for Statistics and Information Analysis in France, specialising in advanced statistical engineering. Lauric has always been interested in applying his knowledge to the health care sector. After internships in both the pharmaceutical industry and at the EHESP School of Public Health in France, he began his PhD with Professor John Terry. His PhD project focused on the analysis of mathematical models using statistical and machine learning techniques.
- PhD Applied Mathematics – University of Exeter
- Engineer diploma - ENSAI
JDRF 2019-2021 Improved, cost effective prediction of type 1 diabetes in early life using combined prediction models (CI 380,760.47)
My research interests are in development and application of machine learning and statistical techniques with practical clinical use.
I am particularly interested by
- Prediction modelling.
- Optimization of cohort design.
- Translation from research to clinical practice
- Improved, cost effective prediction of type 1 diabetes in early life using combined prediction models;
- Identification and follow up optimisation for children with high type 1 diabetes risk;
- Improved, cost effective prediction of celiac disease in early life using combined prediction models.